19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis
Open Access
- 15 April 2020
- journal article
- research article
- Published by Springer Nature in npj Genomic Medicine
- Vol. 5 (1) , 1-5
Abstract
Genomic aberrations of neuroblastoma occurring in late childhood and adolescence are still understudied. Publicly available DNA copy number profiles of 556 tumors (discovery set) and of 208 tumors obtained by array-CGH assay (validation set) were used to test if 19p loss is significantly over-represented in children and adolescents with neuroblastoma. The 19p loss occurrence was separately tested within different age groups in the discovery and validation set and the resulting P values were combined by meta-analysis and corrected by Bonferroni’s method. In both sets, 19p loss was associated with older age at diagnosis. Particularly, the lowest age group significantly associated with 19p loss (discovery set: 20%; validation set: 35%) was 6 years. The 19p loss correlated with inferior overall survival in patients over 6 years of age. Relevant tumor suppressor genes (KEAP1, DNM2, SMARCA4, SLC44A2 and CDKN2D) and microRNAs (miR-181c, miR-27a, and mirR-199a-1) are located in the genomic region involved in 19p loss. Downregulation of DNM2, SLC44A2 and CDKN2D was associated with poor patient outcome and older age. Among the recurrent NB chromosomal aberrations, only 1q gain was enriched in patients older than 6, and its presence was mutually exclusive with respect to 19p loss. Our data demonstrate that 19p loss is a genomic biomarker of NB diagnosed in older children that can predict clinical outcome.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (19255, 20757)
- Ministero della Salute (GR-2011-02348722)
- Fondazione Italiana per la Lotta al Neuroblastoma
- Regione Campania (“SATIN” grant 2018-2020)
- Associazione Oncologia Pediatrica e Neuroblastoma
- Fondazione Umberto Veronesi (NA)
This publication has 29 references indexed in Scilit:
- p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomasHuman Molecular Genetics, 2014
- Neuroblastoma after Childhood: Prognostic Relevance of Segmental Chromosome Aberrations, ATRX Protein Status, and Immune Cell InfiltrationNeoplasia, 2014
- Recurrent SMARCA4 mutations in small cell carcinoma of the ovaryNature Genetics, 2014
- microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRASOncology Reports, 2013
- Neuroblastoma in older children, adolescents and young adults: A report from the International Neuroblastoma Risk Group projectPediatric Blood & Cancer, 2013
- Genetics and Genomics of Neuroblastoma2010
- Germline Nonsense Mutation and Somatic Inactivation of SMARCA4/BRG1 in a Family with Rhabdoid Tumor Predisposition SyndromeThe American Journal of Human Genetics, 2010
- Neuroblastoma in adolescentsCancer, 2006
- Genetic and Epigenetic screening for gene alterations of the chromatin‐remodeling factor, SMARCA4/BRG1, in lung tumorsGenes, Chromosomes and Cancer, 2004
- The Large GTPase Dynamin Associates with the Spindle Midzone and Is Required for CytokinesisCurrent Biology, 2002